Peter Van Endert

18.0k total citations · 5 hit papers
171 papers, 13.6k citations indexed

About

Peter Van Endert is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Peter Van Endert has authored 171 papers receiving a total of 13.6k indexed citations (citations by other indexed papers that have themselves been cited), including 125 papers in Immunology, 61 papers in Molecular Biology and 38 papers in Oncology. Recurrent topics in Peter Van Endert's work include Immune Cell Function and Interaction (77 papers), Immunotherapy and Immune Responses (60 papers) and T-cell and B-cell Immunology (51 papers). Peter Van Endert is often cited by papers focused on Immune Cell Function and Interaction (77 papers), Immunotherapy and Immune Responses (60 papers) and T-cell and B-cell Immunology (51 papers). Peter Van Endert collaborates with scholars based in France, Germany and United States. Peter Van Endert's co-authors include Loredana Saveanu, Guido Kroemer, Laurence Zitvogel, Antoine Tesnière, Theocharis Panaretakis, François Ghiringhelli, Lionel Apétoh, Robert Tampé, Mauro Piacentini and Gian María Fimia and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Peter Van Endert

170 papers receiving 13.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Calreticulin exposure dictates the immunogenicity of cancer cell death

2006 2.5k citations Peter Van Endert, Laurence Zitvogel et al. profile →
Immunogenic death of colon cancer cells treated with oxaliplatin

2009 917 citations Oliver Kepp, Isabelle Martins et al. profile →
Mechanisms of pre‐apoptotic calreticulin exposure in immunogenic cell death

2009 688 citations Oliver Kepp, Peter Van Endert et al. profile →
ER–phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells

2003 593 citations Loredana Saveanu, Peter Van Endert et al. profile →
A viral inhibitor of peptide transporters for antigen presentation

1995 509 citations Peter Van Endert, Robert Tampé et al. profile →

Peers

Countries citing papers authored by Peter Van Endert

Since Specialization

Citations

This map shows the geographic impact of Peter Van Endert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Van Endert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Van Endert more than expected).

Fields of papers citing papers by Peter Van Endert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Van Endert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Van Endert. The network helps show where Peter Van Endert may publish in the future.

Co-authorship network of co-authors of Peter Van Endert

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Van Endert. A scholar is included among the top collaborators of Peter Van Endert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Van Endert. Peter Van Endert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ERAP1-dependent extreme antigen processing efficacy can govern MHC class I expression hierarchy 2025 ·The Journal of Immunology ·(unknown), (unknown), Sylvie Fabrega, (unknown), (unknown), François‐Xavier Mauvais, Rebecca Deprez‐Poulain, Barbara Bertocci, Peter Van Endert	1
2	Insulin-degrading enzyme regulates insulin-directed cellular autoimmunity in murine type 1 diabetes 2024 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), Viv Lindo, Abdelaziz Gdoura, Sylvaine You, F. Susan Wong, Fiona Greer, Peter Van Endert	1
3	TANGO2-related rhabdomyolysis symptoms are associated with abnormal autophagy functioning 2024 ·SHILAP Revista de lepidopterología ·Hortense de Calbiac, (unknown), (unknown), (unknown), (unknown), (unknown), Sorana Ciura, Apolline Imbard, (unknown), Anca Marian, Nicolas Goudin, Laure Caccavelli, Sylvie Fabrega, (unknown), Peter Van Endert, Nicolas Dupont, (unknown), Edor Kabashi, Pascale de Lonlay	3
4	Cross-presentation by the others 2023 ·Seminars in Immunology ·François‐Xavier Mauvais, Peter Van Endert	5
5	Mast cell–mediated inflammation relies on insulin-regulated aminopeptidase controlling cytokine export from the Golgi 2023 ·Journal of Allergy and Clinical Immunology ·Mirjana Weimershaus, Caroline Carvalho, (unknown), (unknown), Michaël Dussiot, Peter Van Endert, Thiago Trovati Maciel, Olivier Hermine	5
6	Insulin-Degrading Enzyme Interacts with Mitochondrial Ribosomes and Respiratory Chain Proteins 2023 ·Biomolecules ·(unknown), Ida Chiara Guerrera, (unknown), Joanna Lipecka, Barbara Bertocci, Peter Van Endert	2
7	Immunosuppression by Mutated Calreticulin Released from Malignant Cells 2019 ·Molecular Cell ·Peng Liu, Liwei Zhao, Friedemann Loos, Caroline Marty, Wei Xie, Isabelle Martins, Sylvie Lachkar, Bo Qu, (unknown), Isabelle Plo, William Vainchenker, Franck Perez, David Rodrı́guez, Carlos López-Otı́n, Peter Van Endert, Laurence Zitvogel, Oliver Kepp, Guido Kroemer	73
8	Tolerogenic Iron Oxide Nanoparticles in Type 1 Diabetes: Biodistribution and Pharmacokinetics Studies in Nonobese Diabetic Mice 2018 ·Small ·(unknown), (unknown), Yoann Lalatonne, Clément Journé, Phalla Ou, Peter Van Endert, Laurence Motte	21
9	UNC93B1 interacts with the calcium sensor STIM1 for efficient antigen cross-presentation in dendritic cells 2017 ·Nature Communications ·Sophia Maschalidi, Paula Nunes, (unknown), (unknown), (unknown), Meriem Garfa‐Traoré, Nicolas Cagnard, Fernando E. Sepulveda, Pablo Vargas, Ana‐Maria Lennon‐Duménil, Peter Van Endert, Thierry Capiod, Nicolas Demaurex, Guillaume Darrasse-Jèze, Bénédicte Manoury	35
10	Fusion Proteins for Versatile Antigen Targeting to Cell Surface Receptors Reveal Differential Capacity to Prime Immune Responses 2010 ·The Journal of Immunology ·Roland Kratzer, François‐Xavier Mauvais, Anne Burgevin, (unknown), Peter Van Endert	29
11	Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance 2009 ·Nature Immunology ·Stefan Tenzer, Edmund G. Wee, Anne Burgevin, Guillaume Stewart-Jones, Lone Smidstrup Friis, Kasper Lamberth, Chih‐Hao Chang, Mikkel Harndahl, Mirjana Weimershaus, Jan Gerstoft, (unknown), Paul Klenerman, Lars Fugger, E. Yvonne Jones, AJ McMichael, Søren Buus, Hansjörg Schild, Peter Van Endert, (unknown)	155
12	Equivalent Specificity of Peripheral Blood and Islet-Infiltrating CD8+ T Lymphocytes in Spontaneously Diabetic HLA-A2 Transgenic NOD Mice 2008 ·The Journal of Immunology ·(unknown), Emanuela Martinuzzi, Philippe Blancou, Jean‐Marie Bach, Roberto Mallone, Peter Van Endert	33
13	Characterizing the N-Terminal Processing Motif of MHC Class I Ligands 2008 ·The Journal of Immunology ·(unknown), Björn Peters, (unknown), Nina D. Ullrich, (unknown), Oliver Carroll, Sascha Bulik, Hans‐Georg Rammensee, Peter Van Endert, Hermann−Georg Holzhütter, Stefan Tenzer, Hansjörg Schild	33
14	Analysis of Direct and Cross-Presentation of Antigens in TPPII Knockout Mice1 2007 ·The Journal of Immunology ·Elke Firat, Jisen Huai, Loredana Saveanu, Simone Gaedicke, Peter Aichele, Klaus Eichmann, Peter Van Endert, Gabriele Niedermann	33
15	Expression of Endoplasmic Reticulum Aminopeptidases in EBV-B Cell Lines from Healthy Donors and in Leukemia/Lymphoma, Carcinoma, and Melanoma Cell Lines 2006 ·The Journal of Immunology ·Doriana Fruci, Silvia Ferracuti, (unknown), (unknown), Ezio Giorda, Rocco Fraioli, Leonardo Sibilio, Oliver Carroll, Akira Hattori, Peter Van Endert, Patrizio Giacomini	77
16	Identifying MHC Class I Epitopes by Predicting the TAP Transport Efficiency of Epitope Precursors 2003 ·The Journal of Immunology ·Björn Peters, Sascha Bulik, Robert Tampé, Peter Van Endert, Hermann−Georg Holzhütter	264
17	Quantifying Recruitment of Cytosolic Peptides for HLA Class I Presentation: Impact of TAP Transport 2003 ·The Journal of Immunology ·Doriana Fruci, Grégoire Lauvau, Loredana Saveanu, Massimo Amicosante, Richard H. Butler, Axel Polack, Florent Ginhoux, François A. Lemonnier, Hüseyin Firat, Peter Van Endert	46
18	Cutting Edge: Invariant Vα14 NKT Cells Are Required for Allergen-Induced Airway Inflammation and Hyperreactivity in an Experimental Asthma Model 2003 ·The Journal of Immunology ·Mariette Lisbonne, Séverine Diem, Alexandre C. Keller, Jean Lefort, (unknown), (unknown), (unknown), Stéphane Sidobre, Mitchell Kronenberg, M Taniguchi, Peter Van Endert, Michel Dy, Philip W. Askenase, Momtchilo Russo, B. Boris Vargaftig, André Herbelin, Maria Leite‐de‐Moraes	247
19	A Region of Tapasin That Affects Ld Binding and Assembly 2001 ·The Journal of Immunology ·Hēth Turnquist, (unknown), A. Reber, (unknown), Suling Li, Ping Wang, Sam D. Sanderson, Brigitte Gubler, Peter Van Endert, Joyce C. Solheim	29
20	Characterization of antigenic peptides presented by HLA-B44 molecules on tumor cells expressing the geneMAGE-3 1996 ·International Journal of Cancer ·Katharina Fleischhauer, Doriana Fruci, Peter Van Endert, Jean Herman, Silvia Tanzarella, (unknown), Pierre G. Coulie, (unknown), Catia Traversari	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact